Dr. Rajeev Agarwal

Dr. Rajeev Agarwal is a distinguished Senior Director of Surgical Oncology at Medanta – The Medicity in Gurugram, with over 47 years of dedicated clinical practice in cancer surgery. He holds an MBBS, MS in Surgery, and a Fellowship in Surgical Oncology, along with an Honorary Doctorate (D.Sc.) from Amity University, Maharashtra, awarded in 2023. Dr. Agarwal is internationally recognized as a pioneer who introduced the practice of surgical oncology and organ-based specialization in oncology to Northern India, fundamentally advancing the standard of cancer care in the region.

With more than 3,000 breast surgeries to his credit, Dr. Agarwal has extensive clinical depth across breast cancer management. He specializes in breast-conserving surgery, sentinel lymph node biopsy, oncoplastic breast surgery, mastectomy, and breast reconstruction. His surgical approach combines oncological safety with aesthetic and functional outcomes, offering patients comprehensive, personalized treatment tailored to their individual presentation and preferences.

Dr. Agarwal treats a significant volume of international patients from the Gulf region, Africa, and beyond who seek his expertise in complex breast and soft tissue oncology. His practice at Medanta ensures access to multidisciplinary care, advanced imaging, and reconstructive options. Patients appreciate his empathetic communication and detailed surgical planning, which reflect his deep engagement with each case.

Medanta – The Medicity is one of India's premier multispecialty healthcare institutions, located in the national capital region. The hospital combines NABH and JCI accreditation with cutting-edge surgical facilities, comprehensive oncology services, and a dedicated international patient team fluent in English and regional languages. The institution's robust infrastructure supports complex oncological procedures and seamless recovery pathways.

International patients choosing Dr. Agarwal at Medanta Gurugram benefit from world-class surgical expertise, transparent communication, and access to a hospital ecosystem designed for both clinical excellence and patient comfort. His membership in the European Society of Medical Oncology underscores his alignment with global oncology standards.